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Breast cancer is the type of cancer that develops from breast
tissue; it is mostly common in women and it is one of the most
studied diseases, largely because of its high mortality (second to
lung cancer). However, it occurs in males also. This article pre-
sents a statistical study of the distribution of age, gender, length
of stay, mode of diagnosis, status (dead or alive) after treatment
and the location of breast cancer among 300 patients admitted in
the University of Ilorin teaching hospital, Ilorin, Nigeria. The
study covers a period of ﬁve (5) years; from 2011 to 2016 and
logistic regression was used to perform the basic analysis in this
study. It was discovered that the age of patients and the location
of the breast cancer (right or left) contributes signiﬁcantly to the
survival of the patients. However, early detection and treatment
of the disease is highly encouraged. This study also recommends
that awareness should be taken to the grassroots and males
should not be excluded from this discussion.
& 2017 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
iversity.edu.ng (P.E. Oguntunde).
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xperimental factors Records of Breast cancer patients obtained from University of Ilorin Teaching
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ata accessibility All the data are available in this data article as supplementary materialsDValue of the data
 The data on breast cancer could be useful for government and health workers to make decisions
that would reduce the risk of breast cancer among the populace.
 The data provides the analysis of the age, gender, location of the breast cancer, mode of diagnosis,
length of stay (LOS), outcome of treatment of breast cancer patients for the population studied.
 The data can further be analyzed using other statistical tools like chi square test, multiple linear
regression and Poisson regression analysis.
 The result from the analysis can be compared with other oncologic studies.
 The interpretation of the data could be helpful in educational studies, epidemiologic oncology,
molecular pathologic epidemiology, and breast cancer awareness, screening and so on.
 The study can be replicated or extended to longitudinal studies.
 The article provides insight on the impact and consequence of age and location of breast cancer on
the survivability of breast cancer patients.1. Data
The data set used in this article was collected as a secondary data and it contains information on
300 breast cancer patients. The data set was obtained from the Cancer Registry Department under the
Department of Admission and Discharge Unit, University of Ilorin Teaching Hospital (UITH) Ilorin,
Nigeria. It involves information on 275 females and 25 males and it covers a period of ﬁve (5) years;
from 2011 to 2016. The patients were all treated as in-patients and were later discharged, of these, 97
patients were discharged dead while 203 patients were discharged alive. The raw data is available
and can be assessed as Supplementary data.
Descriptive analyses were performed and logistic regression analysis was also used to describe and
analyze the data set.
The data is summarized under different classiﬁcations: gender (sex), location of the breast cancer,
mode of diagnosis, survival after treatment, age and length of stay in the hospital during treatment.
1.1. Analysis of age of the patients
The frequency table showing the analysis of the age of all the 300 patients is shown in Table 1.
In Table 1, it can be seen that the mean age of the patients is 49.71 years, the minimum and
maximum ages are 20 years and 96 years respectively. The data set is slightly positively skewed with
a coefﬁcient of skewness of 0.572.
Fig. 1. The distribution of age using histogram.
Table 1
Analysis of age.
Statistics
Age
N Valid 300
Missing 0
Mean 49.71
Median 50.00
Mode 60
Std. Deviation 13.884
Variance 192.768
Skewness .572
Std. Error of Skewness .141
Kurtosis .479
Std. Error of Kurtosis .281
Minimum 20
Maximum 96
Percentiles 25 40.00
50 50.00
75 60.00
Table 2
Classiﬁcation of age of the patients.
Agecode
Frequency Percent Valid Percent Cumulative Percent
Valid o41years 88 29.3 29.3 29.3
41–55years 115 38.3 38.3 67.7
4 55years 97 32.3 32.3 100.0
Total 300 100.0 100.0
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Fig. 2. Bar chart showing the classiﬁcation of age.
Table 3
Classiﬁcation of length of stay.
Loscode
Frequency Percent Valid Percent Cumulative Percent
Valid o 11days 106 35.3 35.3 35.3
11–21days 101 33.7 33.7 69.0
4 21days 93 31.0 31.0 100.0
Total 300 100.0 100.0
Fig. 3. Bar chart showing the classiﬁcation of length of stay.
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Table 4
Distribution of gender of the patients.
Gender/sex Frequency Percent Cumulative Percent
Female 275 91.7 91.7
Male 25 8.3 100.0
Total 300 100.0
Fig. 4. Bar chart showing the distribution of gender.
Table 5
Crosstabulation for gender and outcome of patients.
sex * Outcome Crosstabulation
Count
Outcome Total
Alive Dead
Sex female 188 87 275
male 15 10 25
Total 203 97 300
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The age of the patients were classiﬁed into three different groups (or classes) and the respective
frequencies are as shown in Table 2.
It can be seen from Table 2 that majority (115) of the patients are in the age group 41–55 years
which accounts for 38.3% of the total population under study.
The diagrammatic representation of the information in Table 2 is as shown in Fig. 2.1.2. Analysis on length of stay of the patients at the hospital
Information on the length of stay of the patients in the hospital before discharge is as shown in
Table 3 and the respective frequencies are also displayed.
From Table 3, it can be seen that most (106) of the patients were discharged early and particularly
in less than 11 days.
The diagrammatic representation is as shown in Fig. 3.
Table 7
Classiﬁcation Table.
Classiﬁcation Tablea,b
Observed Predicted
Outcome Percentage Correct
Alive Dead
Step 0 Outcome Alive 203 0 100.0
Dead 97 0 .0
Overall Percentage 67.7
Table 8
Variables in the equation.
B S.E. Wald df Sig. Exp(B)
Step 0 Constant −.738 .123 35.797 1 .000 .478
Table 6
Categorical variable coding.
Frequency Parameter coding
(1) (2)
Loscode o 11days 106 1.00 0.00
11–21days 101 0.00 1.00
4 21days 93 0.00 0.00
Agecode o41years 88 1.00 0.00
41–55years 115 0.00 1.00
4 55years 97 0.00 0.00
Location of Cancer Both breasts 25 1.00 0.00
Left breast 140 0.00 1.00
Right breast 135 0.00 0.00
Mode of Diagnosis Cytological 166 1.00
Histological 134 0.00
sex Female 275 1.00
Male 25 0.00
Table 9
Tests of model coefﬁcients.
Omnibus Tests of Model Coefﬁcients
Chi-square df Sig.
Step 1 Step 20.742 8 .008
Block 20.742 8 .008
Model 20.742 8 .008
Step 2a Step −.892 2 .640
Block 19.850 6 .003
Model 19.850 6 .003
Step 3a Step −.235 1 .628
Block 19.616 5 .001
Model 19.616 5 .001
Step 4a Step −.461 1 .497
Block 19.155 4 .001
Model 19.155 4 .001
a A negative Chi-squares value indicates that the Chi-squares value has decreased from the previous step.
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Table 10
Model summary.
Model Summary
Step -2 Log likelihood Cox & Snell R Square Nagelkerke R Square
1 356.872a .067 .093
2 357.764a .064 .089
3 357.998a .063 .088
4 358.459a .062 .086
a Estimation terminated at iteration number 4 because parameter estimates changed by less than .001.
Table 11
Variables in the equation.
B S.E. Wald df Sig. Exp(B) 95% C.I.for EXP(B)
Lower Upper
Step 1a sex(1) −.232 .454 .261 1 .609 .793 .325 1.932
agecode 9.641 2 .008
agecode(1) −.827 .332 6.194 1 .013 .437 .228 .839
agecode(2) −.875 .309 7.996 1 .005 .417 .227 .765
Location of Cancer 9.209 2 .010
Location of Cancer(1) 1.092 .470 5.407 1 .020 2.981 1.187 7.485
Location of Cancer(2) .721 .276 6.847 1 .009 2.057 1.198 3.531
Mode of Diagnosis(1) −.156 .263 .353 1 .552 .855 .511 1.432
loscode .883 2 .643
loscode(1) −.238 .319 .559 1 .455 .788 .422 1.471
loscode(2) .031 .316 .010 1 .921 1.032 .555 1.918
Constant −.271 .503 .289 1 .591 .763
Step 2a sex(1) −.220 .453 .237 1 .626 .802 .330 1.948
agecode 9.669 2 .008
agecode(1) −.827 .331 6.253 1 .012 .437 .229 .836
agecode(2) −.871 .309 7.964 1 .005 .419 .229 .766
Location of Cancer 9.573 2 .008
Location of Cancer(1) 1.093 .468 5.460 1 .019 2.983 1.193 7.462
Location of Cancer(2) .742 .274 7.323 1 .007 2.100 1.227 3.593
Mode of Diagnosis(1) −.166 .263 .397 1 .529 .847 .506 1.418
Constant −.359 .459 .613 1 .434 .698
Step 3a agecode 10.684 2 .005
agecode(1) −.852 .326 6.814 1 .009 .427 .225 .809
agecode(2) −.898 .304 8.743 1 .003 .407 .225 .739
Location of Cancer 9.389 2 .009
Location of Cancer(1) 1.076 .466 5.325 1 .021 2.933 1.176 7.318
Location of Cancer(2) .728 .272 7.154 1 .007 2.072 1.215 3.533
Mode of Diagnosis(1) −.178 .261 .461 1 .497 .837 .502 1.398
Constant −.528 .303 3.033 1 .082 .590
Step 4a agecode 10.359 2 .006
agecode(1) −.832 .324 6.581 1 .010 .435 .230 .822
agecode(2) −.877 .302 8.446 1 .004 .416 .230 .752
Location of Cancer 9.581 2 .008
Location of Cancer(1) 1.114 .463 5.784 1 .016 3.047 1.229 7.554
Location of Cancer(2) .722 .272 7.055 1 .008 2.059 1.208 3.509
Constant −.640 .256 6.256 1 .012 .528
a Variable(s) entered on step 1: sex, agecode, LocationofCancer, ModeofDiagnosis, loscode.
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Table 12
Hosmer and Lemeshow Test.
Hosmer and Lemeshow Test
Step Chi-square df Sig.
1 8.566 8 .380
2 1.502 8 .993
3 1.380 8 .995
4 1.193 5 .946
Table 13
Classiﬁcation Table.
Observed Predicted
Outcome Percentage Correct
Alive Dead
Step 1 Outcome Alive 187 16 92.1
Dead 74 23 23.7
Overall Percentage 70.0
Step 2 Outcome Alive 193 10 95.1
Dead 81 16 16.5
Overall Percentage 69.7
Step 3 Outcome Alive 180 23 88.7
Dead 68 29 29.9
Overall Percentage 69.7
Step 4 Outcome Alive 180 23 88.7
Dead 68 29 29.9
Overall Percentage 69.7
a. The cut value is .500
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The information on the gender of the patients is as shown in Table 4.
It can be seen in Table 4 that majority (275) of the patients are females. Also, the table revealed the
incidence of breast cancer among male patients.
The information in Table 4 is represented diagrammatically in Fig. 4.2. Experimental design, materials and methods
Research on breast cancer and other form of cancer are intense because of the high fatality rate of
the disease if not properly managed. Several aspects of breast cancer has been studied, some of which
have generated data sets. The analysis on those data sets is based on the various experimental
designs, research materials and referred scientiﬁc methods. Some of such areas are: CT images,
growth factor levels in incident breast cancer, hormone receptor status, cytokine circulation, secre-
tagogue users in breast cancer treatments, chemokine levels, breast cancer and diabetes mellitus co-
infection and treatment, breast cancer and HIV treatment, breast cancer and pregnancy. Others are:
proteome analysis, risk factors analysis, breast examination, screening, management and breast
cancer awareness, epidemiology, risk assessment tools, treatment options: radiotherapy treatment
versus chemotherapy, survival analysis, breast cancer subtypes, biomarkers, socio-cultural barriers to
treatment, socio-demographic factors and alternative medicine approach, genetic risk, dietary pat-
terns, early diagnostics and treatment and others [1–26].
Fig. 5. Diagram of predictive probabilities.
P.E. Oguntunde et al. / Data in Brief 15 (2017) 47–57 55Chi-square test of independence can be used to analyze the data collected, for instance, a cross-
tabulation of gender and outcome of the patients at the point of discharge can be classiﬁed into a r x c
contigency table as shown in Table 5. In this research however, logistic regression analysis was used
to analyze the data set. See similar analysis in [27–30]
Table 6 represents the coding for variables length of stay, age, location of cancer, mode of diagnosis
and gender of the patients.
Table 7 shows the classiﬁcation table at step 0.
Table 8 shows the variables in the equation at Step 0.
Block 1: Method ¼ Backward Stepwise (Conditional).
P.E. Oguntunde et al. / Data in Brief 15 (2017) 47–5756Table 9 shows the omnibus tests of model coefﬁcients.
Table 10 shows the model summary using the log-likelihood, Cox & Snell R square and Negelkerke
R square.
Table 11 shows the variables in the equation from Step 1 to Step 4:
Table 12 shows the Hosmer and Lemeshow Test.
Table 13 shows the classiﬁcation table for all the steps; steps 1–4.
The predictive probability is as shown in Fig. 5.
Breast cancer is one of the dangerous diseases. It occurs in both males and females but the inci-
dence is more in females. Based on this present study, the age of the patient and the location of the
breast cancer (right breast or left breast) both contribute signiﬁcantly to whether a patient would
survive the breast cancer disease or not.Acknowledgement
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